21 maj: CORRECTION: Investeringsforeningen PortfolioManager – optagelse ..
21 maj: Scandinavian Private Equity A/S : Storaktionærmeddelelse
21-05-2019 13:48:01

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 21 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.

1.

Details of the person discharging managerial responsibilities / person closely associated

a) Name Lars Bang

2.

Reason for the notification

a) Position/status Executive Vice President, Product Development & Supply
b) Initial notification/Amendment Initial notification

3.

Details of  the issuer,  emission  allowance  market participant,

auction platform, auctioneer or auction monitor

a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial

instrument, type of instrument

Identification code

Shares

 

 

DK 0010287234

b) Nature of the transaction Sale of Shares
c) Price(s) and volume(s) Price(s) Volume(s)
    DKK 268 29,500
d) Aggregated information

- Aggregated volume

- Price

 
e) Date of the transaction 2019-05-21
f) Place of the transaction NASDAQ Copenhagen XCSE

Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  • spouse or cohabitant
  • dependent children
  • legal entities in which the executive has a controlling influence.

Lundbeck contacts

Investors:

Palle Holm Olesen

Vice President, Investor Relations

PALO@lundbeck.com

+45 30 83 24 26

Media:

Mads Kronborg

Senior Director, Corporate Communication

MAVK@lundbeck.com

+45 36 43 40 00

About H. Lundbeck A/S

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.

An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind

Our approximately 5,000 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programs and our products are available in more than 100 countries. Our research center is based in Denmark and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 18,1 billion in 2018 (EUR 2,4 billion; USD 2,8 billion).

For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck and via LinkedIn.

Attachment

logo.jpg

Relateret indhold
15 aug - 
Lundbeck/UBS: Løfter anbefaling til "køb" fra "neutral"
15 aug - 
Lundbeck/SHB: Kursmålet sænkes til 280 kr. fra 303 kr.
14 aug - 
Onsdagens aktier: Demant toppede indeks der drejede i r..
Relateret debat
22 jul - 
Ups - Pharmacy Benefit Managers - gik lidt for hurtigt ..
22 jul - 
Jeg kan kun støtte Demokraternes tilgang. Det nuværende..
22 jul - 
USA: Trump trækker forslag om ændring af medicinrabatte..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Aktionærer kræver milliarder i erstatning fra Novo Nordisk

16-08-2019 14:38:08
Medicinalvirksomheden Novo Nordisk er blevet sagsøgt af en gruppe aktionærer for at have givet vildledende information til aktiemarkedet.De kræver en samlet erstatning på 11,8 mia. kr. for tab på deres aktier. Det skriver Børsen, hvilket bekræftes af Novo Nordisk i en meddelelse til fondsbørsen.- Novo Nordisk er uenig i anklagerne og er klar til at forsvare selskabet i denne sag, lyder det i medde..

Maersk Drilling får forlænget kontrakt på boreskib i Ækvatorialguinea

16-08-2019 11:03:22
Maersk Drilling har forlænget opholdet for boreskibet Maersk Voyager, der skal bore ude for Ækvatorialguineas kyst.Selskabet har igennem Kosmos Energy forlænget en borekontrakt, der tidligere var indgået med Noble Energy. Det skriver selskabet på Twitter.Originalt skulle Maersk Drilling bore en enkelt brønd for selskabet Noble Energy, og den aftale indeholdt en option på endnu en boring. Den optio..

Aktier/tendens: Fokus på torsdagens regnskaber i positivt marked

16-08-2019 08:19:10
Der er udsigt til en positiv slutning på aktieugen, der han været karakteriseret ved en sværm af regnskaber fra flere C25-selskaber.Futures på de amerikanske aktieindeks stiger 0,7 pct. og det samme er tilfældet for DAX-futuren. De asiatiske aktier ligger også overvejende højere fredag morgen.Torsdagens regnskaber kan påvirke igen fredag, når analytikerne smider regnskaberne i regnearkene og komme..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Fredagens aktier: Gode Carlsberg-takter hjalp Unibrew op på grøn dag
2
USA/strateger: Frygten for recession er overdrevet
3
Coloplast: Direktionsmedlem udnytter optioner og scorer milliongevinst
4
Tivoli/CFO: Vores high end-forretning fungerer rigtig godt

Relaterede aktiekurser

Lundbeck A/S 269,40 0,3% Stigning i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
17. august 2019 15:19:28
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190809.4 - EUROWEB5 - 2019-08-17 15:19:28 - 2019-08-17 15:19:28 - 1 - Website: OKAY